- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Clinical Application of Telbivudine in China. Guest Editor: Prof. Jidong Jia. This supplement was kindly sponsored by Novartis
EDITORIALS
You have free access to this content
A different look at the management of chronic hepatitis B in a resource-constrained country (page 1)
J. Jia
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12056
Treatment of chronic Hepatitis B in resource-constrained countries: an economic solution is required (page 2)
Howard Thomas
REVIEW ARTICLES
Telbivudine treatment in chronic hepatitis B: experience from China (pages 3–8)
H. You and J. Jia
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12058
Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients (pages 9–17)
G.-Q. Wang, Y.-P. Ding and Y.-H. Dong
Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B (pages 18–26)
F.-Q. Hou, X.-J. Wu, Y. Wang, J. Chen, Y.-Z. Liu, Y.-Y. Ren, G. Song, Y.-P. Ding, M. Yu and G.-Q. Wang
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12060
PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication (pages 27–39)
X. F. Wang, Y. Lei, M. Chen, C. B. Chen, H. Ren and T. D. Shi
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12061
Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil (pages 40–45)
Jia-Jie Lu, Kai Liu, Yuan-Ji Ma, Juan Wang, En-Qiang Chen and Hong Tang
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12062
Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil (pages 46–51)
Y. Li, Y. Zhang, J.-P. Wang, J.-Q. Lian and X.-F. Bai
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12063
Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study (pages 52–57)
Z. Huang, Z. Zhao, Y. Zheng, L. Peng, C. Lin, H. Deng and Z. Gao
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12064
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis (pages 58–64)
Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou and Y. Han
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12065
Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy (pages 65–70)
M. Liu, H. Cai and W. Yi
Article first published online: 4 MAR 2013 | DOI: 10.1111/jvh.12066
替比夫定在中国的临床应用。客座编辑:冀东佳教授。由诺华公司慷慨赞助本补充
不同的外观在慢性乙型肝炎的管理在资源有限的国家(第1页)
J.佳
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12056
治疗慢性乙型肝炎在资源有限的国家:一个经济的解决方案是必需的(第2页)
霍华德·托马斯
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12057
评论文章
您可以免费使用这个内容
替比夫定治疗慢性乙型肝炎:来自中
替比夫国的经验(第3-8页)
H.您和J.佳
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12058
替比夫定治疗与高B型肝炎e抗原血清学转换和免疫调节作用,在慢性乙型肝炎患者(第9-17页)
G.-Q.王Y.-P.丁和Y.-H.的董
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12059
快速程序性死亡-1和γ-干扰素诱导蛋白10表达的下调与有利的结果,在抗病毒治疗慢性乙型肝炎(第18-26页)
F.-Q.侯X.-J.吴,王华,陈军,Y.-Z.刘Y.-Y.仁,G.宋,Y.-P.丁,M.羽和G.-Q.的王
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12060
PD-1/PDL1和CD28/CD80通路的调节自然杀伤T细胞的功能,抑制乙肝病毒复制(第27-39页)
XF王,华磊,陈米,陈CB,H.仁和TD轼
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12061
替比夫定联合阿德福韦酯联合治疗和恩替卡韦单药治疗HBeAg阳性慢性乙型肝炎患者耐阿德福韦酯(第40-45页)的疗效和安全性
吕佳杰,刘凯,马源吉,王娟,陈强恩和唐虹
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12062
替比夫定治疗的疗效乙肝e抗原阳性的慢性乙肝患者与阿德福韦酯反应不佳(第46-51页)
Y. Y.李,张,J.-P.王J.-Q.廉和X.-F.的白
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12063
乙肝连续使用替比夫定疗效É抗原阳性的慢性乙肝患者与聚乙二醇干扰素部分响应:一项试验性研究(第52-57页)
Z.黄,Z.赵,郑华,L.鹏,三林,邓H.和Z高
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12064
四十八个星期的回顾性研究中,替比夫定和拉米夫定治疗的患者与乙肝相关肝硬化(第58-64页)
Z.汉族,G. L.夏,华石,朱军,陈华,楼贤,罗高,Z.,J.刘贾,G.,C.李周,X.和Y汉
首次在网上公布:2013年3月4日| DOI:10.1111/jvh.12065
安替比夫定治疗慢性乙型肝炎的整个孕期(第65-70页)
M.刘,蔡H. W.易
文章首次在线发表时间:2013年3月4日| DOI:10.1111/jvh.12066
|
|